Medexus Pharmaceuticals Inc. Q1 Sales Increase

(RTTNews) - Medexus Pharmaceuticals Inc. (MEDXF.OB) reported earnings for first quarter of $0.544 million

The company's bottom line totaled $0.544 million, or $0.02 per share. This compares with $0.516 million, or $0.02 per share, last year.

The company's revenue for the period rose 16.1% to $28.59 million from $24.62 million last year.

Medexus Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings: $0.544 Mln. vs. $0.516 Mln. last year. -EPS: $0.02 vs. $0.02 last year. -Revenue: $28.59 Mln vs. $24.62 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.